EDRH
EW icon

Edmond de Rothschild Holding’s Edwards Lifesciences EW Stock Holding History

Edmond de Rothschild Holding’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$550K Sell
6,084
-26,700
-81% -$2.24M 0.01% 366
2026
Q1 		$2.63M Sell
32,784
-554,913
-94% -$45.7M 0.04% 211
2025
Q4 		$50.1M Sell
587,697
-84,768
-13% -$6.96M 0.71% 34
2025
Q3 		$52.3M Buy
672,465
+1,653
+0.2% +$129K 0.81% 27
2025
Q2 		$52.5M Buy
670,812
+9,364
+1% +$698K 0.84% 25
2025
Q1 		$47.9M Buy
661,448
+15,861
+2% +$1.14M 0.85% 27
2024
Q4 		$47.8M Sell
645,587
-13,747
-2% -$962K 0.82% 28
2024
Q3 		$43.5M Buy
659,334
+559,077
+558% +$40.6M 0.7% 33
2024
Q2 		$9.26M Sell
100,257
-6,629
-6% -$587K 0.16% 126
2024
Q1 		$10.2M Buy
106,886
+10,613
+11% +$892K 0.17% 126
2023
Q4 		$7.34M Buy
96,273
+49,837
+107% +$3.47M 0.13% 143
2023
Q3 		$3.22M Buy
46,436
+11,142
+32% +$895K 0.06% 191
2023
Q2 		$3.33M Sell
35,294
-2,114
-6% -$184K 0.07% 208
2023
Q1 		$3.09M Buy
37,408
+15,282
+69% +$1.2M 0.07% 209
2022
Q4 		$1.65M Buy
22,126
+2,353
+12% +$181K 0.04% 269
2022
Q3 		$1.63M Buy
19,773
+3,300
+20% +$318K 0.04% 261
2022
Q2 		$1.57M Sell
16,473
-41
-0.2% -$4.24K 0.04% 288
2022
Q1 		$1.94M Buy
16,514
+4,610
+39% +$517K 0.04% 262
2021
Q4 		$1.54M Buy
11,904
+9,250
+349% +$1.08M 0.03% 330
2021
Q3 		$300K Buy
+2,654
New +$303K 0.01% 491
2020
Q2 		– Sell
-2,070
Closed -$130K – 618
2020
Q1 		$130K Buy
+2,070
New +$149K 0.01% 371
2019
Q1 		– Sell
-1,110
Closed -$57K – 639
2018
Q4 		$57K Buy
+1,110
New +$56.2K ﹤0.01% 512

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Edmond de Rothschild Holding's EW Position: Q2 2026 in Review

Edmond de Rothschild Holding reduced its Edwards Lifesciences (EW) stake by 81% in Q2 2026, selling an estimated $2.24M and leaving 6,084 shares worth $550K. The position accounts for 0.01% of the portfolio, ranked #366.

Edmond de Rothschild Holding first reported a position in EW in Q4 2018 and has held it in 22 quarters since. The position peaked at $52.5M in Q2 2025. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Edmond de Rothschild Holding held 6,084 shares of Edwards Lifesciences worth $550K as of Q2 2026.
  • Edmond de Rothschild Holding sold 26,700 Edwards Lifesciences shares in Q2 2026, an estimated $2.24M.
  • Edwards Lifesciences made up 0.01% of Edmond de Rothschild Holding's portfolio in Q2 2026, its #366 holding.
  • Edmond de Rothschild Holding first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 22 quarters since.
  • Edmond de Rothschild Holding's Edwards Lifesciences position peaked at $52.5M in Q2 2025.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.